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Abstract
There is still controversy as to how body mass index (BMI) affects male reproduction. We in-
vestigated how BMI is associated with semen quality and reproductive hormones in 166
men, including 38 severely obese men. Standard semen analysis and sperm DNA integrity
analysis were performed, and blood samples were analysed for reproductive hormones.
Adjusted for age and time of abstinence, BMI was negatively associated with sperm con-
centration (B = -0.088, P = 0.009), total sperm count (B = -0.223, P = 0.001), progressive
sperm motility (B = -0.675, P = 0.007), normal sperm morphology (B = -0.078, P = 0.001),
and percentage of vital spermatozoa (B = -0.006, P = 0.027). A negative relationship was
observed between BMI and total testosterone (B = -0.378, P < 0.001), sex hormone binding
globulin (B = -0.572, P < 0.001), inhibin B (B = -3.120, P < 0.001) and anti-Müllerian hor-
mone (AMH) (B = -0.009, P < 0.001). Our findings suggest that high BMI is negatively asso-
ciated with semen characteristics and serum levels of AMH.
Introduction
Like worldwide, the body mass index (BMI) in the Norwegian population is increasing. Data
from national public health surveys show that the proportion of overweight (BMI 25 kg/m2)
and obese (BMI 30 kg/m2) adults is steadily rising, and the largest weight gain is seen in the
male population [1, 2]
Overweight and obesity have a negative effect on female fertility [3]. In comparison, few
studies address the consequence of high BMI on male reproductive health. Epidemiological
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studies have indicated an increased risk of couple infertility with high male BMI [4–6], and dis-
turbance of the the hypothalamic–pituitary–gonadal axis has been proposed as a mechanism
for impaired fertility in overweight and obese men [7]. Only few studies describe the relation-
ship between BMI and semen parameters in a general population. Of these, some authors re-
ported no association between BMI and semen parameters [8–10], whereas others described a
negative association between BMI and sperm concentration [11, 12], total sperm count [12,
13], normal sperm morphology or sperm motility [12, 14]. Studies on the relationship between
BMI and sperm characteristics in men recruited from fertility clinics have reported a negative
association for sperm concentration [15–20], sperm motility [16–18, 20] and numbers of sper-
matozoa with normal morphology [18, 19, 21]. Few studies have investigated DNA damage in
spermatozoa and the relationship to BMI is still unclear [16, 18, 22].
Negative associations between BMI and serum levels of testosterone and sex hormone bind-
ing globulin (SHBG) is well established [9, 11, 15, 18], while luteinizing hormone (LH) and fol-
licle stimulating hormone (FSH) seems to be unaffected by high BMI [9, 11, 18, 23]. As
testosterone is converted to oestradiol by aromatase in adipose tissue, an increase in oestradiol
might be expected when fat mass accumulates. There is evidence for increased oestradiol levels
in obese males [10, 11, 18], however, this is not found in all studies [9, 23].
Anti-Müllerian hormone (AMH) and inhibin B are produced by the Sertoli cells and are
possible markers of spermatogenesis [24–27]. While high BMI has been associated with de-
creasing inhibin B serum levels [11, 28, 29], few studies, with conflicting results, have examined
if there is an association between BMI and AMH [12, 30, 31].
Our aim was to increase the knowledge about the associations between BMI and male repro-
ductive characteristics by including men from the general population and a large group of
obese and severely obese men. We also wanted to explore the relationship between serum
AMH and BMI.
Methods
Participants
The study was conducted at the Faculty of Health Sciences, Oslo and Akershus University Col-
lege of Applied Sciences (HiOA), Oslo, in collaboration with Department of Morbid Obesity
and Bariatric Surgery, Department of Medicine, Oslo University Hospital, Oslo, Morbid Obesi-
ty Center, Vestfold Hospital Trust, Tønsberg and the fertility clinic, Fertilitetsklinikken Sør,
Telemark Hospital, Porsgrunn, all in Norway.
Male participants aged 18 years and older were recruited between 2008 and 2013. Over-
weight and obese men were recruited through advertising in local newspapers, by public no-
tices, from commercial weight loss programmes (Grete Roede AS, Nesbru, Norway) and from
two regional public obesity clinics. Two groups of normal weight men were recruited. The first
group consisted of men from the general population recruited by advertisement. The majority
of men recruited by advertisement were young adults. The second group was recruited from a
fertility clinic and was added to achieve a wider age distribution in the normal weight group.
This group included men from couples with diagnosed female factor infertility, aged 35 years
and older with BMI 18.5–24.9 kg/m2. Semen quality was not an inclusion factor. Upon entry,
participants underwent measurement of height (cm) using a wall mounted stadiometer, and
weight (kg) using a digital scale (Soehnle Professional, Backnang, Germany). Waist circumfer-
ence (cm) was measured by a tape and percentage body fat was obtained using hand-to-hand
bioelectrical impedance analysis (BF306, OMRON Healthcare Ltd, Milton Keynes, UK). Men
recruited from the Telemark Hospital and Vestfold Hospital Trust had their measurements
done by trained staff in the respective hospital, while men recruited from Oslo University
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Hospital had their measurements done at HiOA. In addition, information about smoking sta-
tus, medical treatment and history of cryptorchidism or previous cancer disease was recorded.
Participants received 300 NOK (approximately 36 EUR) upon attendance.
Ethics statement
The study was approved by the Regional Committee for Medical and Health Research Ethics,
South East, Norway. All participants provided a written informed consent.
Semen analysis
Subjects were asked to abstain from ejaculating for 2–7 days prior to sample collection, as rec-
ommended by World Health Organization (WHO) guidelines [32]. The specific length of ab-
stinence time was recorded. Participants received a pre-weighed sample container and semen
sample was obtained by masturbation on-site or at home, if more convenient. Participants
bringing the sample from home were instructed to avoid cooling of the sample by carrying it
close to the body during transportation and to deliver sample within 2 hours after collection.
All semen samples were incubated at 37°C immediately upon arrival. The on-site samples were
liquefied for 30 min before analysis. Otherwise the sample was regarded as liquefied upon ar-
rival. Standard semen analysis was performed according to WHO guidelines [32]. The HiOA
laboratory participates in the European Society of Human Reproduction and Embryology ex-
ternal quality assurance programme for semen analysis. Wet preparations for sperm motility
analysis were recorded by a microscope mounted video camera if the sample reached the labo-
ratory within two hours after collection. Recording was only performed for samples collected
at HiOA as such equipment was not available in the collaborating hospitals. All videos were
sent to Reproductive Medicine Centre, Skåne University Hospital, Malmö, Sweden, for motility
analysis. Semen volume, sperm concentration, total sperm count, sperm morphology and
sperm vitality were assessed at HiOA. Morphology smears were stained by the Papanicolaou
method [32] and analysed according to the Tygerberg strict criteria [33]. Vitality smears were
stained with Sperm VitalStain (Nidacon, Mölndal, Sweden). Semen samples from participants
collected at Vestfold Hospital Trust and Telemark Hospital were prepared in their respective
laboratories and sent to HiOA for analysis within one week. Briefly, stained smears for assess-
ment of sperm vitality and unstained smears for evaluation of sperm morphology were made.
Semen for sperm concentration analysis was diluted 1:5 in buffer containing fixative and stored
at 4°C and 100 ul aliquots of semen were frozen at -80°C.
Sperm chromatin structure assay (SCSA) was performed at Reproductive Medicine Center,
Skåne University Hospital, Malmö, Sweden and details of the method are described elsewhere
[34–36]. Briefly, SCSA is used to distinguish between single stranded and double stranded
DNA by the use of the metachromatic stain acridine orange (AO). AO intercalated in intact
DNA (double-stranded) emits green fluorescence, while AO intercalated with degraded DNA
(single-stranded) emits red fluorescence. The extent of DNA damage is expressed as DNA frag-
mentation index (DFI %), based on the ratio between the red and the total (red plus green)
fluorescence intensity, and is calculated from the DFI frequency histogram obtained by the
flow cytometer. DFI in spermatozoa was analysed with a FACScan flow cytometer (Becton
Dickinson, San Jose, CA, USA), equipped with an air-cooled argon ion laser. A total of 10 000
events were accumulated for each measurement at a flow rate 200–300 cells/sec. Analysis of
flow cytometric data was carried out using the SCSASoft software (SCSA Diagnostics, Brook-
ings, SD, USA). All samples were run in the same batch by one technician and the intra-labora-
tory coefficient of variation (CV) for DFI analysis was 4.5%.
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Hormone analysis
Blood samples were collected before 10 a.m. and centrifuged 30 minutes after collection. Serum
and EDTA-plasma were aliquoted, frozen at -80°C and stored until further analyses were per-
formed. Due to the distance between Vestfold Hospital Trust, Telemark Hospital and HiOA,
blood samples were prepared in the respective laboratories, frozen at -20°C and sent to the
HiOA laboratory. Inhibin B was measured at Labmedicin Skåne Malmö, Sweden. The other
hormones were analysed at Hormone Laboratory, Oslo University Hospital. Total testosterone
was quantified using competitive radioimmunoassay (RIA). Analytic coefficient of variation
(CVA) was 11% at 0.6 nmol/l and 6% at 13.0 nmol/l (Orion Diagnostica, Espoo, Finland).
Sex hormone binding globulin (SHBG) was determined using non-competitive luminometric
assay (ILMA), CVA was 4% at 12 nmol/l, 3% at 56 nmol/l and 6% at 106 nmol/l (Siemens
Healthcare Diagnostics, Tarrytown, NY, USA). Follicle stimulating hormone (FSH) and lutein-
izing hormone (LH) were measured using non-competitive immunofluorometric assay
(IFMA), FSH had a CVA of 2% at 3.6 IU/l, 14.0 IU/l and 70.0 IU/l. LH had a CVA of 5% at
4.3 IU/l and 35.0 IU/l and 6% at 96.0 IU/l (DELFIA kit PerkinElmer Life Science, Wallac Oy,
Turku, Finland). Oestradiol (E2) was quantified using competitive fluoroimmunoassay (FIA),
CVA was 8% at 0.05 nmol/l and 2% at 0.49 nmol/l (PerkinElmer Life Science, Wallac Oy,
Turku, Finland). For analysis of anti-Müllerian hormone (AMH) and inhibin B, enzyme-cou-
pled immunosorbent assay (ELISA) was used. AMH CVA was 6% at 31 pmol/l and 4% at
98 pmol/l. Inhibin B had a CVA at 7% at 19 ng/l and 260 ng/l (Beckman Coulter, Bera, CA,
USA). AMH analysis was performed according to the procedure introduced in June 2013 [37].
Free androgen index was calculated (total testosterone/SHBG x100).
Statistical analyses
Mann-Whitney U test was used to compare semen parameters between normal weight men
and men with BMI 35 kg/m2. Chi-square test with Yates’ correction for continuity was used
to compare the proportions of normal weight men and severely obese men with semen charac-
teristics below the WHO lower reference limits [38]. The proportions of men with serum tes-
tosterone below the lower local reference value were evaluated by Fisher’s exact test.
Relationships between BMI and hormone or semen parameters were addressed by multiple lin-
ear regression analyses. All variables used in the multivariable analyses were continuous. As
there was a significant difference in age between the BMI groups, all data analysed in the re-
gression models were adjusted for age. In the analyses of the data on semen quality, results
were also adjusted for time of abstinence, as number of days varied among the participants. Re-
sidual statistics were investigated for the multiple linear regression models. Dependent vari-
ables were square root or log transformed if the residual distribution violated the model
assumptions. Semen parameters from incomplete semen samples were excluded from the
statistical analyses.
Possible differences in the reproductive characteristics between normal weight men re-
cruited from the fertility clinic and normal weight men recruited by advertising were addressed
by Mann-Whitney U test. As there was a significant difference in age between the subgroups,
hormone levels and semen parameters were compared in a subset encompassing the range of
the 25th to the 75th percentile for age of the whole normal weight group (29–40 years).
Statistical analyses were performed using IBM SPSS Statistics 20, and a P-value of 0.05 or
lower was considered statistically significant. Particular attention should, however, be directed
towards smaller P-values, i.e., those below 0.01, because a considerable number of P-values
have been calculated.
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Results
Study population
In total, 166 men were included in the study after excluding men with azoospermia, cryptorchi-
dism or previous chemotherapy treatment. Characteristics of the population are described in
Table 1. The mean age was 38 years (22–61). The majority of the participants were from Nor-
way or Northern Europe (95%) and a small minority from southern Europe, Asia, Africa and
South America (5%). When divided into BMI groups, 27% of the participants were normal
weight (BMI 18.5–24.9 kg/m2), 31% were overweight (BMI 25–29.9 kg/m2), 19% were obese
(BMI 30–34.9 kg/m2) and 23% were severely obese (BMI 35 kg/m2). The normal weight
group comprised 37 men recruited from the fertility clinic and 33 men recruited by advertising.
Normal weight participants recruited from the fertility clinic had shorter time of abstinence (2
vs. 4 days, P = 0.012) and lower ejaculate volume (median: 3.1 vs 4.1 ml, P = 0.028) than age-
matched men with normal weight recruited by advertisement. However, no significant differ-
ences were found for total sperm count, sperm concentration, sperm morphology, sperm vitali-
ty or for reproductive hormones between the two normal weight subgroups.
BMI and semen parameters
When comparing the normal weight group and the severely obese group, the latter group had
significantly lower total sperm count, progressive sperm motility, normal sperm morphology
and lower percentage of vital spermatozoa (Table 2). The median percentage DFI, as measured
by SCSA was significantly higher in the latter group.
When adjusting for age and time of abstinence in the multiple linear regression model there
was a statistically significant inverse relationship between BMI and sperm concentration, total
sperm count, progressive sperm motility, normal sperm morphology and percentage of vital
spermatozoa. No significant relationship between BMI and DFI was observed in the multiple
Table 1. Characteristics of the participants according to BMI groups.
BMI (kg/m2) 18.5–24.9 25–29.9 30–34.9  35
n 45 52 31 38
BMI (kg/m2)
Median 23.1 27.5 32.5 43.2
Range 18.8–24.9 25.0–29.8 30.0–34.7 35.8–62.7
Age (years)
Median 36 37 39 43
Range 24–54 22–59 23–61 22–59
Waist circumference (cm)
Median 83 99 113 141
Range 73–98 79–112 98–130 118–179
Body fat (%)
Median 17 25 33 41
Range 5–27 18–35 27–38 33–52
Abstinence time (days)
Median 3 3 3 4
Range 1–7 1–14 1–14 2–20
Non-smokers (%) 78 88 87 79
BMI, body mass index.
doi:10.1371/journal.pone.0130210.t001
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regression model adjusted for age and time of abstinence. A larger proportion of severely obese
men had normal sperm morphology and progressive sperm motility below the WHO lower
reference limits [38] than normal weight men (Table 3). The proportions of men with sperm
concentration and total sperm count below the WHO lower reference limits did not differ be-
tween severely obese and normal weight men.
BMI and reproductive hormones
Adjusted for age, BMI correlated negatively with serum levels of total testosterone, SHBG, in-
hibin B and AMH, but no association was found between BMI and free androgen index
(Table 4). Of the severely obese men 34% had serum levels below the lower reference limit for
total testosterone (10 nmol/l), whereas all the normal weight men had testosterone levels above
this value (P = 0.001). A positive association was found between BMI and oestradiol, while no
associations with BMI was found for FSH or LH.
Table 2. Characteristics of semen parameters according to BMI groups, comparison between group 1 and group 4, and associations between BMI
and semen parameters by multiple linear regression.
BMI (kg/m2) 18.5–24.9 25–29.9 30–34.9  35 1 vs. 4 Multiple regression
BMI group 1 2 3 4 P B P 95% CI for B
Sperm cons. (x106/ml)
n 39 47 31 33
Median 53 60 54.9 41.5 0.314 -0.088b 0.009 -0.153,-0.023
Range 1.3–222 3.6–350 3.8–305 3.0–281
Total sperm count (x106)
n 39 47 31 33
Median 205 190 244 121 0.042 -0.223b 0.001 -0.355,-0.091
Range 7–1862 7–601 6–1290 20–1127
Progressive motility (%)
n 21 31 25 17
Median 63 41 43 30 0.001 -0.675 0.007 -1.156,-0.194
Range 17–74 1–76 10–70 0–43
Normal morphology (%)
n 31 40 28 30
Median 5 3 3 2 <0.001 -0.078 0.001 -0.124,-0.032
Range 0–12 1–10 0–7 0–7
Vital sperm (%)
n 34 43 30 34
Median 90 87 88 83 0.002 -0.006b 0.027 -0.001,-0.011
Range 56–97 41–97 50–96 40–95
DFI (%)
n 23 26 28 30
Median 14 16 15 19 0.030 0.002a 0.382 -0.003,0.007
Range 8–39 3–67 6–57 8–85
BMI, body mass index; DFI, DNA fragmentation index; B, regression coefﬁcient; CI, conﬁdence interval.
P-values for differences between group 1 and group 4 were calculated by Mann-Whitney U test. Associations tested by multiple linear regression were
adjusted for age and time of abstinence. All variables in the regression analyses were continuous.
a, log transformed data
b, square root transformed data
doi:10.1371/journal.pone.0130210.t002
BMI and Male Reproductive Characteristics
PLOS ONE | DOI:10.1371/journal.pone.0130210 June 12, 2015 6 / 12
Table 4. Characteristics of reproductive hormones according to BMI group, and associations between BMI and serum hormone levels bymultiple
linear regression.
BMI (kg/m2) 18.5–24.9 25–29.9 30–34.9  35 Multiple regression
n 45 52 31 38 B P 95% CI for B
Total T (nmol/l)
Median 20.7 16.0 14.2 11.1 -0.378 < 0.001 -0.469,-0.289
Range 12.3–35.2 8.5–34.5 4.0–25.1 5.1–17.4
FAI
Median 54.4 55.2 60.9 50.5 -0.161 0.330 -0488,0.165
Range 32.6–97.7 28.7–128.6 25.3–141.3 21.1–101.8
Oestradiol (nmol/l)
Median 0.13 0.14 0.14 0.16 0.001 < 0.001 0.001,0.002
Range 0.09–0.20 0.07–0.23 0.09–0.19 0.11–0.22
SHBG (nmol/l)
Median 38 29 23 26 -0.572 < 0.001 -0.770,-0.380
Range 22–68 14–63 7–51 11–36
FSH (IU/l)
Median 4.1 4.3 3.7 4.3 -0.001a 0.906 -0.003,0.005
Range 1.1–14.9 1.0–11.0 1.4–14.2 1.6–12.2
LH (IU/l)
Median 3.8 3.4 3.1 3.9 0.001a 0.760 -0.003,0.004
Range 1.4–7.5 1.5–9.2 0.9–10.3 1.1–8.2
Inhibin B (ng/l)
Median 202 183 170 123 -3.120 < 0.001 -4.249,-1.958
Range 55–405 71–377 58–298 52–213
AMH (pmol/l)
Median 54 42 34 31 -0.009 a < 0.001 -0.014,-0.005
Range 19–129 14–169 8–176 8–114
T, testosterone; FAI, free androgen index; SHBG, sex hormone binding globulin; FSH, follicle stimulating hormone; LH, luteinizing hormone; AMH, anti-
Müllerian hormone; B, regression coefﬁcient; CI, conﬁdence interval.
Associations tested by multiple linear regression were adjusted for age. All variables in the regression analyses were continuous variables.
a, log transformed data.
doi:10.1371/journal.pone.0130210.t004
Table 3. Proportions of normal weight and severely obesemen with semen parameters below theWHO lower reference limits [38].
BMI (kg/m2) 18.5–24.9  35
n (%) n (%) χ2 (df) P
Sperm concentration < 15 mill/ml 6/41 (15) 5/32 (16) <0.01 (1) 1.000
Total sperm count < 39 mill/ejaculate 5/41 (12) 7/32 (22) 0.62 (1) 0.430
Normal morphology < 4% 13/40 (33) 25/31 (81) 14.40 (1) <0.001
Progressive motility < 32% 4/21 (19) 10/17 (59) 4.79 (1) 0.029
χ2, Chi-square value; df, degrees of freedom.
n (%), number (percentage) of participants with sperm characteristics below WHO lower reference limit/ group total.
Associations were tested by Chi-square test with Yates’ correction for continuity.
doi:10.1371/journal.pone.0130210.t003
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Discussion
In this study, BMI was negatively associated with all semen characteristics explored, except for
DFI. We observed statistically significant negative associations between BMI and sperm con-
centration, total sperm count, progressive sperm motility, sperm vitality and normal sperm
morphology. Severely obese men were more likely to have normal sperm morphology and pro-
gressive sperm motility below the WHO lower reference limits than normal weight men. We
also found a statistically significant negative association between BMI and serum levels of total
testosterone, SHBG, inhibin B and AMH, while serum oestradiol levels were positively associ-
ated with BMI.
Although there are variations in semen quality within each BMI category, we found a signif-
icant decline in all standard semen quality markers with increasing BMI. In other studies sug-
gesting a negative effect of BMI on semen quality, usually one or two semen parameters are
reported to be negatively associated to BMI. This includes a study comprising Danish military
conscripts where lower sperm concentration and sperm count were found at high or low BMI,
but no relation of BMI to other semen parameters [11]. A large number of participants were in-
cluded, however few participants had BMI in the obese range ( 30 kg/m2). Lower ejaculate
volume with increasing BMI and a decline in sperm concentration with increasing waist cir-
cumference was reported in another study, comprising American couples planning to conceive
[13]. A large group of obese men were included, but as semen analysis was performed with
methods other than the WHO standard analysis, the results may not be comparable to our
semen parameters. Both studies were performed on men from the general population, which is
in contrast to the majority of studies on BMI and semen quality where participants recruited
are men with impaired spermatogenesis or men from infertile couples. Hammiche and co-
workers found a negative effect of high BMI on sperm concentration and motility [39], another
group reported a negative correlation with sperm morphology only [23], while a third study
found decreasing ejaculate volume with increasing BMI and lower sperm count in severely
obese men [18]. Two recent meta-analyses have investigated the association between BMI and
semen characteristics or sperm concentration and total sperm count. MacDonald and co-work-
ers were not able to show any association [40], but the analysis was limited by a low number
of included studies. Sermondades group included a larger number of studies and more than
13 000 men [41]. No association was found between BMI and sperm concentration or total
sperm count when comparing means across BMI groups. They found, however, a significantly
increased risk of azoospermia and oligozoospermia in overweight and obese men, indicating
that high BMI may affect sperm production. Both studies comprised men from both normal
population and fertility clinics.
Evaluation of sperm DNA damage by SCSA has been proposed as an additional prognostic
tool to standard semen analysis [42]. A high degree of DNA damage, measured as DFI, is pre-
dictive of prolonged time to pregnancy and increased risk of infertility [43, 44]. Still, the rela-
tionship between BMI and sperm DNA damage is less explored than conventional semen
parameters. Increased DNA damage has been shown in overweight [16] and obese men [16,
18, 22] when compared to normal weight men. However, other studies found no association
between BMI and DFI [12, 45, 46], including a Swedish study comprising men from infertile
couples [47]. Although we found a difference in DFI between the groups with BMI 35 kg/m2
and normal weight, no significant difference was found in the analysis when adjusted for age
and time of abstinence.
Our results for total testosterone and SHBG are in agreement with the majority of studies
of BMI in relation to reproductive hormones [23]. The increased serum insulin levels seen
in obese men leads to down regulation of SHBG synthesis in the liver [48, 49] while excess
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unbound testosterone is converted to oestradiol by aromatase in the adipose tissue. This mech-
anism could explain why we observed no association between BMI and free androgen index.
However, free androgen index does not reflect levels of free testosterone within the testicle.
Our observations of no relationship between BMI and serum levels of LH and FSH is supported
by a majority of studies of overweight and obese men [50]. As serum levels of FSH seem to be
sustained in overweight and obese men, a decrease in semen quality is likely to be influenced
by other factors.
Adipose tissue contains aromatase catalyzing the conversion of testosterone to oestradiol,
which can explain increased oestradiol levels in obese males. In addition, decreased levels of
SHBG may increase the fraction of unbound oestradiol. We observed a positive association be-
tween BMI and oestradiol and the highest levels were seen in men with BMI 35 kg/m2. This
observation is in line with other studies investigating oestradiol in relation to BMI [10–12, 18],
although elevated levels of oestradiol are not found in all studies of overweight and obese men
[23, 29].
We found a significant negative correlation between BMI and serum level of AMH and in-
hibin B, suggesting a possible link between adiposity and Sertoli cell function. The association
between BMI and inhibin B has been reported consistently by others [9–11, 18], while the im-
pact of high BMI on serum AMH, also produced by Sertoli cells, is still uncertain. A twin study
reported reduced AMH levels in obese compared to normal weight men [31], but this result
was opposed by a study of men with normal or reduced sperm concentration and maldecended
testes [51]. Two other studies reported contrasting results as well, but as they included seversly
obese men only, the narrow BMI range may be the cause. Different methodology and lack of
standardization are problematic when comparing these studies. Although AMH analysis in
three of the studies [12, 31, 52] were performed with the same antibody as in our analysis, a
methodological change was introduced in 2013 due to a complement interference phenome-
non causing results lower than expected [37]. To our knowledge, this is the first study to use
the improved AMHmethod and our results strengthen the evidence for a relationship between
BMI and AMH.
The broad BMI range and the large group of obese and severely obese men is a strength of
our study, as is also the large group of men recruited outside fertility clinics. Furthermore, mea-
sures of height and weight were performed by trained staff members to avoid bias due to self-
reporting. All semen samples were analysed strictly according to WHO standards in one single
and experienced laboratory. Limitations to the study include the relatively low number of par-
ticipants. In a recent meta-analysis [41] on BMI and male reproduction the majority of studies
comprised 200 participants or more. However, only one study [14] included men with
BMI 40 kg/m2. Second, recruitment to the study may result in a selection towards subfertile
males, who might have interest in joining a study concerning fertility. Nevertheless, this poten-
tial selection bias should be comparable in all BMI groups. Third, some of our normal weight
participants were recruited at a fertility clinic. By using female infertility and not semen quality
as inclusion criteria, we hypothesized that these men would resemble those recruited by adver-
tisement. This was supported by our subanalysis. Despite significant differences in time of ab-
stinence and ejaculate volume, neither sperm concentration, total sperm count, normal sperm
morphology nor sperm vitality differed between the two subgroups of normal weight men. As
abstinence time and ejaculate volume are associated, the difference might be explained by
stronger motivation among men recruited from a fertility center to comply with semen sample
recommendations. Furthermore, the reproductive characteristics in participants recruited
from obesity centers may differ from men with similar BMI recruited by advertisement.
The effect of weight loss on semen quality is still largely unexplored. Only one study has ad-
dressed the benefits of weight loss on semen quality in a study where obese men participated in
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a weight loss programme focusing on a healthy diet and daily exercise. Weight loss was re-
ported to improve total sperm count and morphology. Whether this improvement was due to
a reduction in BMI or to the improved lifestyle is uncertain. Further studies on how life style
change and weight reduction affect semen quality in obese men could provide information of
clinical value for management of infertile men with high BMI.
In conclusion, BMI was negatively associated with sperm concentration, total sperm count,
progressive sperm motility and sperm morphology. A reduced semen quality was most pro-
nounced in men with BMI above 35 kg/m2. We identified a significant negative association be-
tween BMI and AMH, as also observed with inhibin B. Our results indicate that both sperm
production and sperm maturation are affected by high BMI.
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